Chinese Biopharma Out-Licensing: Ushering in a New Era for UK-China Collaboration in 2025
Disclaimer: This article is intended for industry professionals and provides general educational information only. It does not promote specific products or constitute medical advice. Introduction The global pharmaceutical landscape is undergoing rapid transformation, with Chinese biopharma companies emerging as major innovators and highly sought-after partners for international collaborations. In 2025, out-licensing deals from Chinese […]